Abstract

Introduction: Emerging evidence suggests that cancer genetic services are less likely to be delivered in Low-to-Middle Income Countries (LMIC). Anecdotal evidence from clinical practice suggests that women decline genetic testing mainly due to high self-funded cost and low uptake of risk-reduction measures. Here, we aim to assess awareness of breast cancer inherited risk and willingness to accept genetic testing in low-resource settings.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call